Literature DB >> 11709543

Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.

S Aradhya1, T Bardaro, P Galgóczy, T Yamagata, T Esposito, H Patlan, A Ciccodicola, A Munnich, S Kenwrick, M Platzer, M D'Urso, D L Nelson.   

Abstract

The X-linked dominant and male-lethal disorder incontinentia pigmenti (IP) is caused by mutations in a gene called NEMO (IKK-gamma). We recently reported the structure of NEMO and demonstrated that most IP patients carry an identical deletion that arises due to misalignment between repeats. Affected male abortuses with the IP deletion had provided clues that a second, incomplete copy of NEMO was present in the genome. We have now identified clones containing this truncated copy (Delta NEMO) and incorporated them into a previously constructed physical contig in distal Xq28. Delta NEMO maps 22 kb distal to NEMO and only contains exons 3-10, confirming our proposed model. A sequence of 26 kb 3' of the NEMO coding sequence is also present in the same position relative to the Delta NEMO locus, bringing the total length of the duplication to 35.5 kb. The LAGE2 gene is also located within this duplicated region, and a similar but unique LAGE1 gene is located just distal to the duplicated loci. Mapping and sequence information indicated that the duplicated regions are in opposite orientation. Analysis of the great apes suggested that the NEMO/LAGE2 duplication occurred after divergence of the lineage leading to present day humans, chimpanzees and gorillas, approximately 10-15 million years ago. Intriguingly, despite this substantial evolutionary history, only 22 single nucleotide differences exist between the two copies over the entire 35.5 kb, making the duplications >99% identical. This high sequence identity and the inverted orientations of the two copies, along with duplications of smaller internal sections within each copy, predispose this region to various genomic alterations. We detected four rearrangements that involved NEMO, Delta NEMO or LAGE1 and LAGE2. The high sequence similarity between the two NEMO/LAGE2 copies may be due to frequent gene conversion, as we have detected evidence of sequence transfer between them. Together, these data describe an unusual and complex genomic region that is susceptible to various types of pathogenic and polymorphic rearrangements, including the recurrent lethal deletion associated with IP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709543     DOI: 10.1093/hmg/10.22.2557

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  Inverted repeat structure of the human genome: the X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes.

Authors:  Peter E Warburton; Joti Giordano; Fanny Cheung; Yefgeniy Gelfand; Gary Benson
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

2.  The LCR at the IKBKG locus is prone to recombine.

Authors:  Francesca Fusco; Michele D'Urso; Maria Giuseppina Miano; Matilde Valeria Ursini
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

3.  Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients.

Authors:  Raphael B Parmigiani; Fabiana Bettoni; Maria D Vibranovski; Marilene H Lopes; Waleska K Martins; Isabela W Cunha; Fernando A Soares; Andrew J G Simpson; Sandro J de Souza; Anamaria A Camargo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

4.  Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation.

Authors:  Masaru Imamura; Tomoki Kawai; Satoshi Okada; Kazushi Izawa; Takayuki Takachi; Haruko Iwabuchi; Sakiko Yoshida; Ryosuke Hosokai; Hirokazu Kanegane; Tatsuo Yamamoto; Hajime Umezu; Ryuta Nishikomori; Toshio Heike; Makoto Uchiyama; Chihaya Imai
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

5.  Identification and expression analysis of novel LAGE-1 alleles with single nucleotide polymorphisms in cancer patients.

Authors:  Yi Shao; Zhen-Yuan Sun; Shi-Wei Sun; Yi Zhao; Wan Yee Sin; Yan-Hua Yuan; Andrew J Simpson; Lloyd J Old; Xin-Ting Sang; Yi-Lei Mao; Yong Xie; Jie-Fu Huang; Hai-Tao Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-25       Impact factor: 4.553

6.  Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination.

Authors:  Joke Vandewalle; Hilde Van Esch; Karen Govaerts; Jelle Verbeeck; Christiane Zweier; Irene Madrigal; Montserrat Mila; Elly Pijkels; Isabel Fernandez; Jürgen Kohlhase; Christiane Spaich; Anita Rauch; Jean-Pierre Fryns; Peter Marynen; Guy Froyen
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

7.  Clinical Utility Gene Card for: incontinentia pigmenti.

Authors:  Francesca Fusco; Alessandra Pescatore; Julie Steffann; Ghislaine Royer; Jean-Paul Bonnefont; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

8.  Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation.

Authors:  J J Cox; S T Holden; S Dee; J I Burbridge; F L Raymond
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

9.  Inverted low-copy repeats and genome instability--a genome-wide analysis.

Authors:  Piotr Dittwald; Tomasz Gambin; Claudia Gonzaga-Jauregui; Claudia M B Carvalho; James R Lupski; Paweł Stankiewicz; Anna Gambin
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

10.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.